Benign neoplasm: Ascending colon

CD2_BENIGN_ASCENDING_COLON_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.2& Hospital discharge: ICD-8 — 21133 Cause of death: ICD-10 — D12.2& Cause of death: ICD-8 — 21133 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum coli ascendentis

NAME	CD2_BENIGN_ASCENDING_COLON_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D122
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21133
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D122
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21133
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Ascending colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Ascending colon

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4885	2403	2482
Unadjusted period prevalence (%)	0.96	0.82	1.09
Median age at first event (years)	68.42	67.09	69.72

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4204: Matched controls
42038

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

9.8

323.0

822

1020

UJF32

NOMESCO Finland

Coloscopy

15.9

323.0

3177

6837

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

26.1

323.0

504

218

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

27.5

323.0

1527

854

UJF30

NOMESCO Finland

Ileoscopy through colon

7.9

323.0

1151

1918

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

29.6

323.0

770

316

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

357

C61

ICD-10 Finland

Malignant neoplasm of prostate

336.3

323.0

366

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

322

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

13.0

323.0

710

647

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

18.1

323.0

928

648

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4503599627370496.0

323.0

4195

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.9

323.0

1696

5092

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

26.2

323.0

686

310

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

25.7

314.5

449

195

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

310.2

1976

8243

116

Kela drug reimbursment

Prostate cancer

+∞

225.0

214

JN4BD

NOMESCO Finland

Extensive body CT

7.0

222.8

597

975

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

214.4

204

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

67.5

203.9

236

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

109.4

200.2

218

H02AB02

ATC

dexamethasone; systemic

19.7

186.3

288

156

L01BC06

ATC

capecitabine; oral

+∞

185.8

177

115

Kela drug reimbursment

Breast cancer

+∞

176.3

168

PJA12

NOMESCO Finland

Sentinel node biopsy

357.5

172.6

173

A04AA02

ATC

granisetron; systemic, transdermal

224.0

167.4

172

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

164.6

157

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

77.0

162.0

184

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

4.6

158.8

615

1522

WF002

NOMESCO Finland

Radical radiotherapy

67.5

151.3

175

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

148.8

142

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

142.3

2185

13431

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

138.8

754

2495

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1366.5

136.2

132

JN4AD

NOMESCO Finland

Body CT examination

6.6

134.6

368

602

L02AE02

ATC

leuprorelin; implant, parenteral

59.5

131.5

155

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1286.5

128.8

125

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

124.2

1612

8947

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.4

116.4

1277

6472

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

294.4

112.6

114

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

111.4

1329

6995

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

107.7

103

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

541.3

107.2

106

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

106.7

102

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.4

102.3

327

646

N02BE01

ATC

paracetamol; systemic, rectal

2.5

100.9

3685

30930

B01AB05

ATC

enoxaparin; parenteral

2.2

100.7

1416

7961

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

100.0

592

2050

A02BC02

ATC

pantoprazole; systemic

2.0

99.8

2857

21418

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

99.3

Y77

ICPC

Malignant neoplasm prostate

147.7

95.5

101

WX302

NOMESCO Finland

Thoracal epidural anesthesy

7.0

94.8

246

371

WF049

NOMESCO Finland

Radiotherapy of metastasis

907.4

91.1

L02BB03

ATC

bicalutamide; oral

+∞

90.9

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

90.8

1080

5574

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

89.9

JFB30

NOMESCO Finland

Right hemicolectomy

24.1

89.7

129

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

87.9

647

2575

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

86.7

1138

6121

HAC20

NOMESCO Finland

Total mastectomy

294.3

85.0

WX002

NOMESCO Finland

Sedation and analgesia

2.2

84.7

1034

5372

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

84.6

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.1

83.7

519

1842

L02BG04

ATC

letrozole; oral

30.2

83.0

112

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

82.5

ZX090

NOMESCO Finland

Other technic of radiotherapy

92.0

81.3

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

44.4

80.8

100

JFA42

NOMESCO Finland

Endoscopic injection in colon

31.9

79.7

106

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

206.3

78.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

78.4

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

75.0

77.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

77.0

622

2601

WF003

NOMESCO Finland

Adjuvant radiotherapy

105.8

76.1

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

384.1

76.0

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

195.9

74.4

L03AA13

ATC

pegfilgrastim; parenteral

+∞

73.1

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

72.9

573

2350

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

10.5

72.1

144

141

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.1

71.7

118

A04AA01

ATC

ondansetron; systemic, rectal

6.5

71.3

194

312

J01DB01

ATC

cefalexin; oral

2.0

71.2

3328

27739

L02BA01

ATC

tamoxifen; oral

80.6

70.2

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

46.1

70.1

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

87.2

69.1

K92.1

ICD-10 Finland

Melaena

3.5

68.1

337

1007

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

65.9

1401

8910

N02AX02

ATC

tramadol; systemic, rectal

1.8

65.0

1834

12784

B01AB10

ATC

tinzaparin; parenteral

3.7

64.9

301

852

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

63.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

63.6

907

4953

XKD00

NOMESCO Finland

Uroflowmetry

2.2

63.4

775

3960

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

63.4

417

1528

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

219.9

63.3

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.1

63.3

373

1269

S18

ICPC

Laceration/cut

1.8

62.5

1784

12430

JN4CD

NOMESCO Finland

Very extensive body CT

6.3

62.0

171

280

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

616.9

61.9

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

9.7

61.9

129

137

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

19.8

61.0

ZX120

NOMESCO Finland

Intravenous

2.9

61.0

402

1472

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

59.5

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.4

59.4

307

947

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

59.3

771

4033

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

586.0

58.8

K63.5

ICD-10 Finland

Polyp of colon

7.9

58.6

138

180

XX3DW

NOMESCO Finland

Time consuming IT work

3.4

58.5

299

914

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

58.5

HA1AA

NOMESCO Finland

X-ray mammography

4.8

58.4

203

437

P01AB01

ATC

metronidazole; oral, rectal

1.7

58.1

1584

10807

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

56.6

397

1510

UJH02

NOMESCO Finland

Anoscopy

3.7

55.9

264

757

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.7

55.5

405

1575

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

285.1

55.3

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

55.2

630

3105

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

55.0

782

4234

A02BC05

ATC

esomeprazole; systemic

1.7

54.4

1718

12176

R4110

NOMESCO Finland

Physiotherapy

1.8

54.1

1115

6915

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.5

53.6

164

306

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

53.2

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

85.5

53.0

H02AB06

ATC

prednisolone; systemic

1.7

52.8

1940

14308

C50.99

ICD-10 Finland

Breast, unspecified

524.2

52.6

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

52.2

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

51.9

354

1320

J01MA02

ATC

ciprofloxacin; systemic

1.7

51.2

1622

11440

A02BC03

ATC

lansoprazole; oral

1.7

50.8

1339

8947

L03AA02

ATC

filgrastim; parenteral

55.3

50.7

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

50.5

449

1949

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

50.1

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

21.5

50.1

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.6

49.1

179

405

Z51.5

ICD-10 Finland

Palliative care

4.8

48.4

169

366

WX110

NOMESCO Finland

Local anesthesy

1.6

48.0

2548

20494

NK6AN

NOMESCO Finland

Total body bone isotope imaging

24.6

48.0

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.3

47.8

257

815

R06.0

ICD-10 Finland

Dyspnoea

1.8

47.3

1126

7259

A04AA55

ATC

palonosetron, combinations; systemic

+∞

46.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

46.0

452

2062

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

45.9

UKC02

NOMESCO Finland

Cystoscopy

1.9

45.3

715

3998

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

44.9

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

44.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

44.9

N03AX16

ATC

pregabalin; oral

1.8

44.6

981

6150

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

43.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

43.8

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

43.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

43.8

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

19.7

43.5

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.1

43.2

581

3047

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4.4

42.8

162

381

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

42.8

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

61.9

42.2

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

79.3

41.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

41.3

441

2088

J01MA12

ATC

levofloxacin; systemic

1.9

41.2

758

4462

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

41.0

670

3783

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

40.7

K62.7

ICD-10 Finland

Radiation proctitis

+∞

40.7

C03CA01

ATC

furosemide; systemic

1.6

40.7

1342

9414

L57.0

ICD-10 Finland

Actinic keratosis

2.3

40.5

396

1799

D75

ICPC

Malignant neoplasm colon/rectum

66.3

40.1

SPAT1153

SPAT

Removal of sutures

1.6

40.0

1325

9295

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

48.5

39.8

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.9

39.7

133

276

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

39.6

WX402

NOMESCO Finland

General anaesthesia

2.0

39.3

530

2777

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

39.2

1415

10132

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.2

39.1

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

201.8

38.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

201.8

38.9

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

38.6

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

18.7

38.3

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.9

38.3

165

438

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

38.2

441

2162

D01

ICPC

Abdominal pain/cramps general

2.2

38.2

422

2029

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.3

37.6

198

618

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

370.5

37.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.4

36.9

186

561

C50

ICD-10 Finland

Malignant neoplasm of breast

191.6

36.8

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

36.5

TQW99

NOMESCO Finland

Other minor procedure on skin

3.2

35.8

196

630

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

35.7

905

5862

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

35.5

A04AD12

ATC

aprepitant; systemic

+∞

35.5

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

8.8

35.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

35.3

690

4125

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.0

35.3

ZXC96

NOMESCO Finland

Robot assisted procedure

11.1

35.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

34.8

1599

12042

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

124.4

34.7

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

34.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

34.4

L02BX02

ATC

degarelix; parenteral

+∞

34.4

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

34.4

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

32.5

34.4

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

57.6

34.2

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

339.8

33.9

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

339.8

33.9

R03AC02

ATC

salbutamol; inhalant

1.5

33.9

1964

15541

L02BG03

ATC

anastrozole; oral

76.8

33.8

J01AA02

ATC

doxycycline; systemic

1.5

33.7

3109

27199

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

33.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

33.4

WZC30

NOMESCO Finland

Teaching

2.1

33.3

416

2102

N02AA05

ATC

oxycodone; systemic

2.0

33.1

485

2615

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

33.1

251

994

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.5

33.0

158

458

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

32.9

1199

8518

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

32.9

389

1923

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

171.3

32.7

A02BC01

ATC

omeprazole; systemic

1.6

32.6

1158

8175

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

32.4

226

852

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

32.3

729

4546

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

32.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

32.3

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

32.0

475

2572

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

319.3

31.9

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.0

31.9

131

334

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

31.8

1765

13768

J01CA04

ATC

amoxicillin; systemic

1.5

31.6

3043

26625

ZXA00

NOMESCO Finland

Right side

1.6

31.5

1135

8026

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.4

31.4

159

482

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

31.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

31.3

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.6

31.1

111

247

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

31.0

297

1329

C07AB07

ATC

bisoprolol; oral

1.5

30.9

2131

17347

WF001

NOMESCO Finland

Preoperative radiotherapy

161.1

30.7

AA1AD

NOMESCO Finland

CT of head and brain

1.6

30.5

1061

7432

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

30.3

223

866

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

13.8

30.2

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

30.2

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

30.2

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

30.2

A79

ICPC

Malignancy NOS

38.3

30.2

E0000UV

ATC

1.5

29.8

1441

10868

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

29.7

1091

7729

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

29.7

223

876

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

29.2

M79.6

ICD-10 Finland

Pain in limb

1.5

29.2

1390

10438

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

29.1

711

4524

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.4

29.0

147

447

C05AA08

ATC

fluocortolone; rectal, topical

1.8

28.8

600

3638

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

28.7

1472

11219

R50.9

ICD-10 Finland

Fever, unspecified

1.9

28.5

475

2678

N05CF01

ATC

zopiclone; oral

1.5

28.2

1264

9349

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

28.1

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

28.1

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

28.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

28.1

1777

14109

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

10.7

27.9

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

10.7

27.9

ZZR00

NOMESCO Finland

Flap of skin

7.9

27.8

A02BA02

ATC

ranitidine; systemic

1.6

27.8

843

5682

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

283.2

27.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

27.7

314

1519

XJH00

NOMESCO Finland

Transanal ultrasonography

2.3

27.7

278

1275

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

145.9

27.6

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

3.2

27.5

147

465

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

19.7

27.3

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

27.1

110

278

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

27.1

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

27.1

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

27.1

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

27.0

401

2164

JFF23

NOMESCO Finland

Transversostomy

15.3

26.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

26.8

365

1906

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

272.7

26.7

N06AX11

ATC

mirtazapine; oral

1.5

26.7

1186

8734

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

26.7

571

3487

S29

ICPC

Skin symptom/complaint other

1.7

26.6

664

4244

SPAT1263

SPAT

Sampling

1.4

26.5

1647

12987

A06AD11

ATC

lactulose; oral

1.7

26.4

593

3672

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

26.4

206

828

K64.0

ICD-10 Finland

First degree haemorrhoids

5.2

26.2

159

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

26.2

571

3506

WW500

NOMESCO Finland

Blood transfusion

3.6

26.1

120

338

L02BG06

ATC

exemestane; oral

+∞

26.1

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

26.1

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

26.1

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

26.1

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

26.0

186

711

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

60.4

26.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

25.9

435

2456

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

25.7

179

675

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

25.7

1642

12992

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

94.0

25.7

G04CA02

ATC

tamsulosin; oral

1.5

25.6

1003

7174

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

25.6

214

894

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

25.4

2606

22488

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

25.3

682

4444

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.1

25.3

S77

ICPC

Malignant neoplasm of skin

22.7

25.2

R01AD09

ATC

mometasone; nasal

1.4

25.1

1544

12113

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

25.0

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

25.0

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

25.0

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

25.0

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

25.0

A07AA02

ATC

nystatin; oral

2.2

25.0

265

1247

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

24.7

149

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

24.7

281

1360

128

Kela drug reimbursment

Cancers of female genital organs

251.5

24.7

X76

ICPC

Malignant neoplasm breast female

90.6

24.7

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

15.5

24.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

24.5

162

592

K59.0

ICD-10 Finland

Constipation

2.2

24.3

257

1206

A07EC02

ATC

mesalazine; oral, rectal

2.3

24.1

223

982

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

24.0

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

24.0

ZXA05

NOMESCO Finland

Left side

1.5

23.9

1035

7549

L02AE04

ATC

triptorelin; parenteral

67.8

23.8

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.5

23.8

WX892

NOMESCO Finland

Monitored bed care

2.0

23.5

322

1683

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.6

23.5

180

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

9.2

23.4

M04AA01

ATC

allopurinol; systemic

1.7

23.4

559

3518

M54.5

ICD-10 Finland

Low back pain

1.5

23.3

1173

8815

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.8

23.3

100

267

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

23.2

780

5364

J02AC01

ATC

fluconazole; systemic

1.4

23.2

1294

9923

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

23.0

229

1046

SPAT1254

SPAT

Administration of medicine

1.7

22.8

568

3613

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

22.8

234

1083

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

22.8

221

995

TJF80

NOMESCO Finland

Ostomy education

13.6

22.7

D06

ICPC

Abdominal pain localized other

2.0

22.6

303

1571

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

22.6

391

2226

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.0

22.4

236

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

22.4

278

1398

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.8

22.4

158

C10AA05

ATC

atorvastatin; oral

1.4

22.2

1733

14103

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

22.1

186

781

A06AC51

ATC

ispaghula, combinations; systemic

2.3

22.0

217

986

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

21.9

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

21.9

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

21.8

284

1456

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

18.5

21.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

115.6

21.6

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

7.0

21.6

R53

ICD-10 Finland

Malaise and fatigue

1.5

21.5

761

5288

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

21.5

2467

21372

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.5

21.4

100

287

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

16.3

21.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.8

21.3

140

511

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

21.3

608

4007

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.2

21.2

200

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

21.0

922

6713

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

20.9

940

6874

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

20.8

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

20.8

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

20.8

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

20.8

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

20.8

700

4801

D18

ICPC

Change in faeces/bowel movements

3.3

20.7

105

322

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

210.9

20.6

D11

ICPC

Diarrhoea

1.8

20.6

347

1958

C08CA01

ATC

amlodipine; oral

1.4

20.5

1557

12556

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

20.4

294

1565

UJG02

NOMESCO Finland

Proctoscopy

3.4

20.4

100

298

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

41.8

20.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

20.4

298

1596

R06AE07

ATC

cetirizine; oral

1.4

20.4

1472

11766

D16

ICPC

Rectal bleeding

3.2

20.3

106

332

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

20.3

572

3756

Z31.5

ICD-10 Finland

Genetic counselling

3.1

20.1

115

383

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

20.1

383

2248

Z71.8

ICD-10 Finland

Other specified counselling

1.5

20.0

774

5477

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

20.0

1221

9462

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

20.0

160

654

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

19.9

1052

7932

B01AA03

ATC

warfarin; systemic

1.5

19.9

921

6768

H02AB07

ATC

prednisone; oral

1.6

19.9

540

3507

TQW20

NOMESCO Finland

Tatoe

57.8

19.9

A98

ICPC

Health maint/preventive medicine

1.7

19.9

3847

36434

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.4

19.8

A07EA06

ATC

budesonide; oral, local oral

2.7

19.8

140

535

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

19.8

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

19.8

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

19.8

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

19.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.7

19.8

238

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

19.8

745

5239

R42

ICD-10 Finland

Dizziness and giddiness

1.5

19.7

883

6444

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

73.8

19.7

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

19.6

205

956

L03AA14

ATC

lipegfilgrastim; parenteral

200.8

19.6

R31

ICD-10 Finland

Unspecified haematuria

1.8

19.5

388

2307

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

40.2

19.5

JG1CG

NOMESCO Finland

Extensive MRI of rectum

21.7

19.5

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.8

19.5

125

451

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.5

19.3

156

SPAT1104

SPAT

Monitoring of emergency patient

1.9

19.3

291

1576

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

19.3

1010

7596

J01FA06

ATC

roxithromycin; oral

1.4

19.3

1480

11921

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

19.1

251

1292

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.9

19.0

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.1

18.9

116

K30

ICD-10 Finland

Functional dyspepsia

1.7

18.9

389

2338

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

18.8

159

669

B01AB04

ATC

dalteparin; parenteral

2.2

18.8

189

865

WX320

NOMESCO Finland

Spinalanesthesy

1.5

18.8

891

6569

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

18.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

18.8

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

18.8

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

13.4

18.7

JAH01

NOMESCO Finland

Laparoscopy

2.8

18.7

125

463

SPAT1301

SPAT

No procedures

1.4

18.7

1235

9687

N05CF02

ATC

zolpidem; oral

1.6

18.6

602

4084

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

18.5

460

2915

L03

ICPC

Low back symptom/complaint

1.5

18.5

877

6460

R03BA02

ATC

budesonide; inhalant

1.5

18.5

632

4345

M03BX02

ATC

tizanidine; oral

1.3

18.4

2179

18742

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

18.4

108

368

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

5.8

18.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

18.3

898

6661

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

44.2

18.2

H02AB04

ATC

methylprednisolone; systemic

1.6

18.2

553

3692

A04

ICPC

Weakness/tiredness general

1.6

18.1

473

3037

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.1

18.1

G47.3

ICD-10 Finland

Sleep apnoea

1.5

18.1

807

5873

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

17.9

282

1552

J45

ICD-10 Finland

Asthma

1.7

17.8

356

2116

R03AC03

ATC

terbutaline; inhalant

1.6

17.8

505

3314

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

3.2

17.8

304

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

17.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

17.7

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

17.7

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

17.7

L02BB04

ATC

enzalutamide; oral

+∞

17.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

17.6

158

689

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

180.6

17.5

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

17.4

502

3304

R51.80

ICD-10 Finland

Headache

1.6

17.4

450

2881

J01DA01

ATC

[U] cefalexin; systemic

1.3

17.4

2304

20079

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

18.7

17.3

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.7

17.3

204

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

42.1

17.3

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.3

17.2

R18

ICD-10 Finland

Ascites

4.1

17.2

166

R4190

NOMESCO Finland

Nutritional therapy

3.2

17.1

279

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

17.1

608

4210

ZQZ00

NOMESCO Finland

Treatment of several skin areas

14.8

17.1

R11

ICD-10 Finland

Nausea and vomiting

1.9

17.1

265

1451

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

17.1

2132

18396

R02

ICPC

Shortness of breath/dyspnoea

1.6

17.0

478

3130

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

17.0

1905

16180

D02

ICPC

Abdominal pain epigastric

2.0

16.9

216

1101

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.3

16.9

145

JG1BG

NOMESCO Finland

MRI of rectum

21.9

16.8

A02BC04

ATC

rabeprazole; oral

1.8

16.8

316

1845

J01MA14

ATC

moxifloxacin; systemic

1.8

16.8

314

1828

207

Kela drug reimbursment

Chronic arrhythmias

1.5

16.8

660

4670

R03DC03

ATC

montelukast; oral

1.6

16.8

533

3597

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.7

1858

15741

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

16.7

1139

8942

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

16.7

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

16.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

16.7

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

16.7

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

16.7

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

16.7

R35

ICD-10 Finland

Polyuria

1.9

16.6

269

1495

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

5.7

16.6

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

90.4

16.6

Z51.0

ICD-10 Finland

Radiotherapy session

90.4

16.6

K62.1

ICD-10 Finland

Rectal polyp

4.2

16.5

153

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

170.6

16.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

16.5

1054

8185

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

17.9

16.4

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

16.4

200

999

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

16.3

614

4299

JFB46

NOMESCO Finland

Resection of sigmoid colon

4.4

16.3

132

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

16.2

1061

8266

SPAT1262

SPAT

Handing over of treatment supplies

1.5

16.2

733

5335

A10BH01

ATC

sitagliptin; oral

1.6

16.1

425

2734

J01FA10

ATC

azithromycin; systemic

1.3

16.1

1880

16011

TKE10

NOMESCO Finland

Puncture of prostate

30.1

16.1

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

16.1

108

402

A11CC03

ATC

alfacalcidol; systemic

2.8

16.0

103

372

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

16.0

273

1546

D64.8

ICD-10 Finland

Other specified anaemias

3.3

16.0

250

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

15.9

646

4595

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

15.9

304

1784

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.1

15.9

290

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

15.7

407

2603

T90

ICPC

Diabetes non-insulin dependent

1.4

15.7

978

7545

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

15.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

15.6

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

15.6

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

15.6

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

15.5

176

852

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

15.5

568

3956

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

160.5

15.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

160.5

15.5

R07.3

ICD-10 Finland

Other chest pain

1.7

15.5

360

2237

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

15.4

582

4075

ZXC20

NOMESCO Finland

Use of chemical agents

3.7

15.4

184

R60.0

ICD-10 Finland

Localized oedema

1.6

15.3

421

2738

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

15.3

593

4177

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

15.3

3326

30874

ZX112

NOMESCO Finland

Subcutaneous

5.2

15.2

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

15.2

157

731

C10AA01

ATC

simvastatin; oral

1.3

15.2

1970

16969

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

15.2

1789

15211

SPAT1255

SPAT

Intravenous administration of medicine

1.8

15.1

247

1376

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

23.4

15.1

WX290

NOMESCO Finland

Other blockade of nerve

1.3

15.0

1260

10190

S21

ICPC

Skin texture symptom/complaint

1.6

15.0

443

2935

S82

ICPC

Naevus/mole

1.6

14.9

397

2558

127

Kela drug reimbursment

Transplant complication

4.1

14.8

140

Z01.2

ICD-10 Finland

Dental examination

1.3

14.8

1327

10830

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.0

14.8

285

JN6AD

NOMESCO Finland

CT of torso and neck

7.9

14.8

A11

ICPC

Chest pain NOS

1.7

14.8

324

1983

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

14.7

287

GDC00

NOMESCO Finland

Lobectomy of lung

25.1

14.7

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

14.6

308

1863

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

14.6

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

14.6

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

14.6

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

14.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

14.6

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

14.6

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

14.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

14.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

14.6

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

14.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

14.6

1593

13375

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

14.6

138

619

JFB43

NOMESCO Finland

Left hemicolectomy

7.7

14.6

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

80.4

14.6

C90.0

ICD-10 Finland

Multiple myeloma

80.4

14.6

G04BE03

ATC

sildenafil; oral

6.3

14.5

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

14.5

281

1658

R13

ICD-10 Finland

Dysphagia

1.8

14.5

245

1383

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

150.4

14.5

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

150.4

14.5

C09CA06

ATC

candesartan; oral

1.4

14.5

801

6044

N05BA04

ATC

oxazepam; oral

1.4

14.4

853

6514

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

14.4

1212

9794

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.5

14.4

112

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

14.3

1137

9105

R03BB04

ATC

tiotropium bromide; inhalant

1.6

14.3

418

2760

J01FF01

ATC

clindamycin; systemic

1.4

14.3

946

7359

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

14.2

1385

11434

G44.2

ICD-10 Finland

Tension-type headache

1.6

14.2

419

2772

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.3

14.1

224

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

14.1

117

490

M25.5

ICD-10 Finland

Pain in joint

1.4

14.1

977

7653

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.9

14.1

147

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

14.0

191

999

I84

ICD-10 Finland

Hemorrhoids

2.4

14.0

120

513

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

4.9

14.0

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

13.9

791

5990

C10AC01

ATC

colestyramine; oral

2.6

13.9

102

400

A01

ICPC

Pain general/multiple sites

1.7

13.9

282

1685

J01EA01

ATC

trimethoprim; systemic

1.4

13.9

829

6335

ZX080

NOMESCO Finland

Image guided radiotherapy

53.5

13.8

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

13.8

254

1476

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

13.8

403

2658

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

13.7

1149

9265

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.7

1411

11723

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.7

830

6356

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

13.7

459

3126

A10AE04

ATC

insulin glargine; parenteral

1.6

13.7

367

2370

Z93.3

ICD-10 Finland

Colostomy status

9.7

13.7

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.2

13.7

136

623

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

13.7

154

748

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.5

13.6

107

435

ICD-10 Finland

2.5

13.6

105

425

WF090

NOMESCO Finland

Profylactic radiotherapy

75.3

13.6

R19.4

ICD-10 Finland

Change in bowel habit

2.6

13.6

100

393

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

13.6

1505

12625

D07AC01

ATC

betamethasone; topical

1.3

13.5

1252

10240

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

13.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

13.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

13.5

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

13.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

13.5

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.7

13.5

163

R01AD08

ATC

fluticasone; nasal

1.4

13.5

913

7117

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

140.4

13.4

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

8.8

13.4

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

13.4

169

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

13.4

182

949

R05

ICD-10 Finland

Cough

1.4

13.4

692

5148

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

13.4

130

591

N03AX12

ATC

gabapentin; oral

1.5

13.4

568

4071

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

13.3

1292

10633

B82

ICPC

Anaemia other/unspecified

2.4

13.2

108

449

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

13.2

1345

11137

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.8

13.2

293

N19

ICD-10 Finland

Unspecified kidney failure

2.1

13.2

145

697

A10BA02

ATC

metformin; oral

1.3

13.1

1159

9405

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.2

13.1

118

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

13.1

485

3375

L02AE03

ATC

goserelin; implant

7.5

13.1

A46

ICD-10 Finland

Erysipelas

1.5

13.1

541

3854

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

13.1

556

3985

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.9

13.1

203

1112

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

13.1

1181

9618

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

15.1

13.1

L04AX01

ATC

azathioprine; systemic

2.1

13.0

151

740

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

13.0

492

3442

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

13.0

488

3410

K57

ICD-10 Finland

Diverticular disease of intestine

2.6

12.9

369

SPAT1285

SPAT

Provision of consultation response

1.8

12.9

213

1193

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

12.9

250

C03DA01

ATC

spironolactone; oral

1.5

12.8

430

2934

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

12.8

380

2519

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.9

12.8

136

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

12.7

460

3189

N06AX16

ATC

venlafaxine; oral

1.6

12.6

374

2475

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

12.6

577

4194

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

12.6

248

1469

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

70.0

12.6

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

70.0

12.6

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

7.8

12.6

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

32.1

12.6

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

12.6

605

4441

-60

ICPC

Result test/procedure

1.8

12.5

232

1350

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

12.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

12.5

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

12.5

1CD02

NOMESCO Finland

+∞

12.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

12.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

12.5

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

12.5

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

+∞

12.5

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

12.5

A12AA04

ATC

calcium carbonate; oral

3.0

12.5

229

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

12.5

612

4508

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

12.5

151

754

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

130.3

12.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

130.3

12.4

A28

ICPC

Limited function/disability NOS

1.4

12.3

581

4247

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.0

12.3

161

829

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.2

12.3

198

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

12.3

404

2739

R63.4

ICD-10 Finland

Abnormal weight loss

2.1

12.3

139

677

A07EA02

ATC

hydrocortisone; rectal

2.6

12.3

349

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.5

12.2

367

D12

ICPC

Constipation

2.1

12.2

145

718

KE1BG

NOMESCO Finland

MRI of prostate

10.5

12.2

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

9.6

12.2

HA1HA

NOMESCO Finland

Tomosynthesis mammography

37.6

12.2

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

12.2

256

1549

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

12.1

235

1386

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

12.1

223

1296

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.5

12.1

163

M01AX17

ATC

nimesulide; oral

1.3

12.1

939

7464

R33

ICD-10 Finland

Retention of urine

1.6

12.1

293

1845

TK800

NOMESCO Finland

Hemodialysis

2.6

12.0

339

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.9

12.0

252

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

12.0

117

532

-50

ICPC

Medication/prescr/renewal

2.0

12.0

161

839

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

11.9

152

778

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

13.4

11.9

JAH00

NOMESCO Finland

Laparotomy

2.6

11.9

343

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.6

11.9

145

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.8

11.9

K78

ICPC

Atrial fibrillation/flutter

1.6

11.9

346

2280

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.3

11.9

182

S04

ICPC

Lump/swelling localized

1.6

11.8

293

1857

RD210

NOMESCO Finland

3.1

11.8

205

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

11.8

102

440

JFB00

NOMESCO Finland

Partial resection of small intestine

3.4

11.8

162

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

11.8

348

2304

B07.9

ICD-10 Finland

Verruca simplex

2.4

11.7

101

432

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

11.7

233

M05BX04

ATC

denosumab; parenteral

2.0

11.7

145

733

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.7

849

6679

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.1

11.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

65.1

11.6

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

65.1

11.6

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

65.1

11.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

11.6

2371

21321

C09CA01

ATC

losartan; oral

1.3

11.6

968

7771

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

11.6

391

N06AB10

ATC

escitalopram; oral

1.4

11.6

552

4043

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

11.6

289

1834

K51.5

ICD-10 Finland

Left sided colitis

2.4

11.5

411

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

11.5

287

1819

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

11.5

289

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

11.5

177

972

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

11.5

195

1103

8211/2-C18.2

ICD-O-3

Tubular adenocarcinoma in situ of ascending colon

+∞

11.5

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

11.5

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

11.5

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

11.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

11.5

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

+∞

11.5

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

11.5

L02BX03

ATC

abiraterone; oral

+∞

11.5

L01CA04

ATC

vinorelbine; systemic

+∞

11.5

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

11.5

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

11.5

A08

ICPC

Swelling

1.9

11.4

158

831

G04CA01

ATC

alfuzosin; oral

1.5

11.4

457

3235

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

11.4

620

4649

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

11.3

278

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

11.3

185

1035

L01

ICPC

Neck symptom/complaint

1.5

11.3

449

3169

L60.0

ICD-10 Finland

Ingrowing nail

2.0

11.3

145

743

S26

ICPC

Fear of cancer of skin

4.3

11.3

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.8

11.3

126

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

11.3

577

4276

KAC10

NOMESCO Finland

Total nephrectomy with capsule

15.0

11.3

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

35.1

11.3

D02AE01

ATC

carbamide; topical

1.7

11.2

232

1396

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

11.2

179

KED22

NOMESCO Finland

Transurethral resection of prostate

1.7

11.2

232

1398

XF404

NOMESCO Finland

Ambulatory ECG

1.5

11.2

371

2517

M01AE02

ATC

naproxen; oral, rectal

1.3

11.2

1943

17106

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

11.2

381

2602

B80

ICPC

Iron deficiency anaemia

2.7

11.2

265

C08CA13

ATC

lercanidipine; oral

1.4

11.1

525

3830

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

11.1

238

1448

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

25.1

11.1

R15

ICD-10 Finland

Faecal incontinence

2.2

11.1

109

500

H01CB02

ATC

octreotide; parenteral

20.1

11.1

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

20.1

11.1

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.8

11.1

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

11.1

364

2464

J20

ICD-10 Finland

Acute bronchitis

1.6

11.1

318

2089

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.7

11.0

285

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

11.0

822

6482

E000001

ATC

1.4

11.0

644

4885

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.5

11.0

338

M48.0

ICD-10 Finland

Spinal stenosis

1.4

11.0

511

3720

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

11.0

797

6257

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1168

2233

6.56

307.65

4.5

1.4

7.9

9.0

ug/l

0.07

1000

1663

(3022145) Colonoscopy Study observation

2128

3894

8.91

307.65

1.6

1.3

—

(40768804) Tissue Pathology biopsy report

2609

12643

3.28

307.65

2.6

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3243

19319

3.02

286.60

7.1

3.8

11.7

12.0

umol/l

0.61

3105

18049

(4035726)

572

1157

5.47

271.18

1.4

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2867

16865

2.69

243.75

6.1

3.8

35.1

35.4

g/l

3.23

2713

15324

(3013650) Neutrophils [#/volume] in Blood by Automated count

3306

21078

2.76

235.47

10.3

6.3

4.2

4.3

e9/l

2.80

2900

18012

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4178

30386

3.59

230.00

10.0

5.4

81.5

76.3

u/l

5.45

4008

28036

(3044640) Blood type and Crossmatch panel - Blood

2031

11159

2.40

184.05

3.0

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1938

10432

2.42

183.92

2.9

2.3

3.3

2.9

mg/l

7.55

1724

8817

(3001604) Monocytes [#/volume] in Blood

2939

19086

2.36

178.75

7.0

5.3

0.6

e9/l

0.23

2545

16265

(3006315) Basophils [#/volume] in Blood

2951

19221

2.35

177.88

7.0

5.4

0.0

e9/l

0.18

2550

16402

(3013115) Eosinophils [#/volume] in Blood

3013

19870

2.35

175.35

7.3

5.5

0.2

e9/l

1.99

2632

17187

(3019198) Lymphocytes [#/volume] in Blood

2982

19598

2.34

174.68

7.1

5.4

1.9

1.8

e9/l

0.51

2587

17009

(40768797) Stomach Pathology biopsy report

1245

5607

2.64

171.36

1.3

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2834

18593

2.25

161.49

7.5

5.3

1.2

mmol/l

0.97

2624

16368

(3048689) Calprotectin [Mass/mass] in Stool

997

4181

2.74

156.76

2.4

2.1

139.4

153.4

ug/g

0.46

809

3255

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2631

17009

2.19

152.08

4.6

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

1699

9277

2.27

149.21

5.3

3.5

87.6

86.3

1.20

1674

9022

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2999

20524

2.19

148.46

9.0

5.7

1.2

mmol/l

2.32

2693

17142

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1603

8593

2.29

146.67

2.9

2.1

—

(40758558) Short blood count panel - Blood

1634

8868

2.27

144.78

7.6

4.7

—

(3002256) Pathology report gross observation

795

3086

2.88

143.86

1.4

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2443

15627

2.13

141.63

3.9

2.8

132.3

136.2

ug/l

0.28

2273

14177

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

345

790

4.62

139.22

3.5

1.8

2539.7

112.7

u/ml

0.72

296

631

(3022948) Iron [Moles/volume] in Serum or Plasma

1287

6408

2.37

138.80

3.3

2.5

11.9

12.8

umol/l

3.76

1211

5841

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

934

4016

2.64

138.18

4.1

2.7

228.1

240.2

u/l

3.23

886

3705

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1144

5485

2.42

133.76

3.3

2.7

21.0

22.5

2.39

998

4546

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1199

5877

2.38

133.32

3.3

2.6

2.3

g/l

1.52

1132

5365

(3019069) Monocytes/100 leukocytes in Blood

2638

17803

2.05

127.45

7.6

5.9

8.8

0.11

2494

16379

(3013707) Erythrocyte sedimentation rate by Westergren method

3878

30292

2.36

127.06

5.3

4.2

14.8

12.7

mm/h

12.32

3638

27743

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2050

12645

2.07

126.80

2.9

2.3

59.3

u/l

0.00

1927

11516

(3031040) Bacteria [#/volume] in Urine by Automated count

3521

26475

2.18

126.35

6.1

4.5

1127.2

2242.1

e6/l

0.48

408

(3006504) Eosinophils/100 leukocytes in Blood

2621

17713

2.04

125.36

7.3

5.6

2.8

3.0

2.15

2477

16224

(3018010) Neutrophils/100 leukocytes in Blood

2646

18007

2.02

123.34

7.1

5.6

58.7

57.8

3.13

2480

16561

(42870588) Differential panel, method unspecified - Blood

2076

12988

2.04

122.29

6.8

5.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1273

6621

2.25

121.59

1.4

1.3

2.5

2.6

g/l

0.75

717

3709

(3032080) INR in Blood by Coagulation assay

2547

17177

2.01

120.94

12.3

10.6

1.3

inr

0.71

583

4739

(3002030) Lymphocytes/100 leukocytes in Blood

2656

18182

2.01

120.79

7.4

5.8

26.1

27.2

4.98

2491

16623

(3022096) Basophils/100 leukocytes in Blood

2541

17223

1.99

117.79

7.3

5.6

0.7

0.23

2399

15799

(3013826) Glucose [Moles/volume] in Serum or Plasma

3261

24135

2.06

117.46

6.1

4.4

6.9

6.8

mmol/l

0.63

3085

22496

(3027945) Reticulocytes/100 erythrocytes in Blood

993

4744

2.37

115.18

2.6

2.1

1.8

1.35

892

4108

(3015377) Calcium [Moles/volume] in Serum or Plasma

2033

12847

2.00

114.30

3.8

2.1

2.4

mmol/l

0.66

1743

10620

(3023368) Bacteria identified in Blood by Culture

1782

10830

2.02

111.20

5.1

3.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

714

2975

2.64

110.80

2.5

2.0

0.2

g/l

4.52

672

2680

(3014576) Chloride [Moles/volume] in Serum or Plasma

1023

5046

2.30

109.61

7.3

6.3

104.3

104.2

mmol/l

0.26

1012

4917

(3037467) Urinalysis macro (dipstick) panel - Urine

3586

27813

2.09

109.03

5.8

4.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1386

7864

2.06

103.20

1.3

1.2

1.6

1.9

u/ml

0.37

308

2038

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2658

18862

1.90

101.55

2.4

2.1

94.2

94.6

pmol/l

0.19

1506

9557

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4560

39610

3.27

100.34

23.6

13.6

25.8

24.1

mg/l

2.77

3918

31053

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

741

3295

2.47

99.67

2.8

2.2

48.9

53.7

u/l

0.10

640

2784

(3030467) Casts [#/volume] in Urine by Automated count

1764

11126

1.92

95.30

4.0

3.0

0.4

0.5

e6/l

0.50

1372

8281

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1237

6906

2.06

95.06

3.4

2.6

1.0

1.2

e6/l

1.49

747

4005

(3023520) Reticulocytes [#/volume] in Blood

770

3587

2.36

92.92

2.8

2.2

71.1

68.5

e9/l

1.15

602

2739

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

508

1944

2.80

92.35

1.8

1.6

1.5

g/l

0.83

450

1657

(3018095) Leukocytes [#/volume] in Urine

2091

14079

1.85

90.90

4.8

3.5

65.0

115.1

e6/l

3.55

1527

9892

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

627

2706

2.51

89.36

1.8

1.6

—

(36304419) Bacteria [Presence] in Urine

1687

10668

1.89

89.04

3.9

2.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

815

3968

2.26

88.33

3.1

2.2

9.1

7.9

umol/l

0.76

720

3390

(3018418) pH of Serum or Plasma

1828

11920

1.85

87.10

5.2

3.3

7.4

0.11

218

2105

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1115

6251

2.02

83.19

3.7

2.8

2.4

2.5

e6/l

0.07

634

3382

(3000991) Gas panel - Venous blood

696

3270

2.32

81.64

8.3

7.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3106

24036

1.80

81.01

3.9

3.0

62.7

48.8

u/l

8.14

2877

21818

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1053

5874

2.01

79.21

3.6

2.4

0.8

mmol/l

5.99

978

5363

(3009261) Glucose [Presence] in Urine by Test strip

2684

19993

1.76

78.92

5.0

3.8

0.0

estimate

1.60

360

3320

(3035350) Ketones [Presence] in Urine by Test strip

2656

19730

1.76

78.81

4.9

3.8

0.0

estimate

0.50

368

3382

(3011397) Hemoglobin [Presence] in Urine by Test strip

1543

9801

1.84

78.11

5.0

3.8

—

(3002582) Erythrocytes [#/volume] in Urine

1801

12052

1.78

76.20

4.2

3.1

82.9

73.4

e6/l

0.10

1405

9152

(3019309) Folate [Moles/volume] in Red Blood Cells

1454

9124

1.85

76.19

1.8

1153.3

1167.6

nmol/l

0.22

1154

6800

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1241

7410

1.90

76.00

3.5

2.2

2.5

2.4

mmol/l

3.14

1076

6338

(3014111) Lactate [Moles/volume] in Serum or Plasma

715

3503

2.22

75.45

6.8

6.4

1.3

1.4

mmol/l

1.69

682

3377

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2019

14001

1.75

75.21

3.5

3.1

1639.5

1469.4

ng/l

0.94

1798

12057

(3003396) Base excess in Arterial blood by calculation

884

4723

2.06

74.46

6.9

6.8

1.0

1.3

mmol/l

0.86

697

3656

(3003458) Phosphate [Moles/volume] in Serum or Plasma

931

5088

2.03

73.59

7.8

5.3

1.1

1.0

mmol/l

0.98

877

4659

(3027801) Oxygen [Partial pressure] in Arterial blood

886

4764

2.05

73.22

6.9

6.8

11.8

11.6

kpa

0.45

834

4532

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

541

2382

2.43

73.13

2.8

2.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

886

4767

2.05

73.08

6.9

6.8

5.1

kpa

0.40

835

4548

(3021601) Nitrite [Presence] in Urine by Test strip

2633

19778

1.72

72.59

6.7

5.0

0.0

estimate

0.80

384

3430

(3021960) Folate [Moles/volume] in Serum or Plasma

1615

10653

1.77

70.52

1.7

1.5

20.7

20.6

nmol/l

0.10

1431

8916

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2332

17059

1.70

69.91

4.7

3.9

49.4

75.3

ng/l

0.94

1785

12538

(40761511) CBC panel - Blood by Automated count

4559

41006

2.68

67.05

22.2

13.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

193

496

4.01

66.49

2.6

1.9

200.3

319.4

u/ml

0.21

181

447

(3020630) Protein [Mass/volume] in Serum or Plasma

693

3531

2.12

65.59

2.6

1.6

66.2

66.8

g/l

1.08

634

3121

(3000570) Elastase.pancreatic [Mass/mass] in Stool

314

1110

2.95

65.54

1.5

1.4

266.7

288.4

ug/g

0.98

188

663

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1719

11783

1.71

64.00

3.8

2.6

33.6

34.7

u/l

0.26

1621

11032

(3014007) Fractional oxyhemoglobin in Arterial blood

540

2523

2.28

63.32

8.2

8.6

93.8

93.4

0.83

540

2511

(3019550) Sodium [Moles/volume] in Serum or Plasma

4642

42304

2.96

63.18

27.9

16.6

139.6

139.8

mmol/l

3.61

4573

41125

(3042936) Bacteria identified in Isolate by Culture

954

5511

1.91

63.14

2.2

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

260

844

3.20

62.86

1.7

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3644

30536

1.76

62.06

4.5

3.9

15.0

pmol/l

0.05

3350

27298

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1057

6360

1.84

61.36

2.5

1.9

30.3

30.0

0.85

1027

6157

(3026493) Urate [Moles/volume] in Serum or Plasma

1630

11114

1.70

61.27

3.2

2.5

3306.0

5891.2

umol/l

2.00

1427

9380

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1324

8524

1.76

61.22

2.1

1.7

1.3

1.2

mg/l

0.19

1017

6537

(3020779) Urea [Moles/volume] in Serum or Plasma

687

3575

2.07

61.20

9.7

6.7

11.7

10.9

mmol/l

2.15

662

3379

(3023103) Potassium [Moles/volume] in Serum or Plasma

4642

42400

2.91

61.05

28.1

16.7

4.0

mmol/l

0.13

4566

41150

(3016502) Oxygen saturation in Arterial blood

786

4303

1.99

60.77

7.3

7.1

95.5

95.1

0.89

763

4126

(3026782) Osmolality of Urine

1221

7717

1.78

60.00

3.4

2.7

546.0

546.4

mosm/kgh2o

0.02

1042

6421

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

459

2045

2.37

59.98

7.9

8.8

24.3

24.5

mmol/l

0.52

412

1879

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

645

3302

2.10

59.95

4.8

3.7

110.7

94.0

ng/l

3.73

569

2764

(3000850) Epithelial cells [#/volume] in Urine

1308

8436

1.75

59.88

2.9

2.5

4.6

5.0

e6/l

0.41

1132

7267

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

335

1287

2.72

59.75

3.7

3.0

0.3

u/ml

1.80

190

739

(3021589) Normoblasts [#/volume] in Blood

2275

17084

1.62

57.49

11.7

8.7

0.0

e9/l

0.51

1859

13951

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4257

37688

2.01

57.42

20.6

12.7

73.9

75.4

ml/min/173m2

4.87

3638

30326

(40768800) Prostate Pathology biopsy report

134

292

4.69

57.15

1.2

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

717

3888

1.99

56.67

7.7

7.5

118.0

122.1

g/l

5.91

701

3728

(40761535) Cells panel - Urine sediment

693

3720

2.01

56.35

4.5

3.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

727

3999

1.96

55.02

5.1

3.6

5.8

kpa

0.00

703

3885

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4631

42559

2.70

54.29

15.3

9.5

25.3

25.4

u/l

0.07

4545

40578

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4633

42599

2.70

54.02

28.1

15.9

86.5

80.5

umol/l

14.85

4633

42583

(3026008) Bacteria identified in Urine by Culture

1764

12584

1.63

53.96

4.0

3.2

—

(3002032) Base excess in Venous blood by calculation

719

3983

1.94

53.16

5.2

3.6

1.7

2.0

mmol/l

1.35

607

3260

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2221

16791

1.59

53.09

2.6

2.2

78.1

79.3

nmol/l

1.25

2001

14638

(3014765) Yersinia sp identified in Stool by Organism specific culture

285

1076

2.75

52.48

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1062

6667

1.76

52.42

2.1

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4191

37187

1.89

52.07

5.7

4.7

2.0

2.1

mu/l

1.55

3918

33481

(42529406) Shigella sp [Presence] in Stool by Culture

285

1083

2.73

51.82

1.3

1.2

—

(3012544) pH of Venous blood

732

4152

1.90

50.19

5.2

3.6

—

7.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

279

1069

2.71

49.90

1.3

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1003

6318

1.74

48.44

34.3

29.4

1.6

1.4

inr

1.15

868

(3004588) Protein electrophoresis panel - Serum or Plasma

578

3071

2.00

47.93

2.2

1.5

—

(3044889) 12 lead EKG panel

3447

29256

1.61

47.29

5.1

4.1

—

(3019150) Specific gravity of Urine by Refractometry

1328

9102

1.63

46.23

5.5

4.3

1.0

kg/l

0.56

219

1365

(3004716) Salmonella sp identified in Stool by Organism specific culture

342

1511

2.36

45.23

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

3930

34602

1.69

45.11

25.8

15.2

38.1

39.4

11.38

2601

22131

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

486

2479

2.07

44.99

1.8

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

779

4658

1.80

44.69

2.0

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

777

4662

1.79

44.00

2.0

1.7

—

(36660697) Celiac disease serology panel - Serum

537

2864

1.98

43.87

1.2

—

(3007461) Platelets [#/volume] in Blood

4688

43872

2.70

43.10

36.4

20.2

243.2

244.0

e9/l

0.35

4616

42482

(3007853) Bacteria identified in Skin by Aerobe culture

763

4581

1.79

43.04

2.1

1.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

4689

43892

2.70

42.97

36.7

20.3

131.3

135.9

g/l

72.79

4647

43068

(3024731) MCV [Entitic volume]

4688

43882

2.69

42.89

36.3

20.1

91.7

91.5

1.72

4647

43050

(3035941) MCH [Entitic mass]

4688

43884

2.69

42.85

36.2

20.1

30.4

1.61

4647

43054

(3026361) Erythrocytes [#/volume] in Blood

4688

43888

2.69

42.77

36.4

20.2

4.4

4.5

e12/l

42.45

4605

42320

(3010813) Leukocytes [#/volume] in Blood

4688

43892

2.69

42.69

36.5

20.2

6.9

6.7

e9/l

2.06

4608

42316

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

394

1898

2.17

42.28

5.5

4.0

24.0

24.2

mmol/l

0.65

347

1674

(3003327) Ova and parasites identified in Stool by Light microscopy

265

1086

2.52

41.28

1.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

535

2915

1.94

40.93

1.7

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

480

2534

1.99

40.23

2.5

2.3

10.5

10.8

g/l

0.70

451

2304

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1839

13924

1.51

40.01

2.3

2.2

192.6

227.6

u/l

1.04

1724

12932

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4267

38771

1.79

39.65

7.9

6.5

41.1

40.7

mmol/mol

2.01

4027

35531

(3024354) Oxygen [Partial pressure] in Venous blood

589

3345

1.87

39.63

4.1

3.0

4.6

4.5

kpa

0.40

568

3237

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2491

20135

1.48

38.93

2.7

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

897

5819

1.66

37.77

10.9

7.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

712

4350

1.75

37.41

2.6

2.4

6.1

7.4

ug/l

1.33

632

3767

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

555

3158

1.85

36.99

1.7

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

570

3275

1.84

36.82

2.9

2.4

61.6

62.4

ml/min/173m2

0.18

267

1252

(3000494) Fungus identified in Specimen by Culture

740

4597

1.72

36.56

1.5

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

395

2012

2.05

36.48

2.0

1.4

1.1

g/l

1.40

366

1808

(3037121) Protein [Mass/volume] in Urine

287

1295

2.29

36.04

3.3

2.4

0.4

g/l

0.17

141

429

(3013139) Helicobacter pylori Ag [Presence] in Stool

490

2714

1.90

35.47

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

259

1129

2.37

35.22

3.4

1.5

43.8

29.5

u/ml

0.88

248

1069

(46235355) HIV 1 and 2 tests - Meaningful Use set

627

3755

1.77

35.18

1.7

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

348

1738

2.08

33.85

2.1

1.4

7.5

g/l

0.02

248

1262

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1735

2.08

33.64

2.2

1.4

4.0

3.8

g/l

0.91

235

1216

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1737

2.07

33.54

2.2

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

303

1451

2.16

32.87

2.4

1.5

1.0

0.5

g/l

1.66

257

1223

(40768793) Breast Pathology biopsy report

220

4.10

32.39

1.2

—

(3037756) Immunofixation for Serum or Plasma

205

835

2.52

32.33

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

10.68

32.20

5.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

338

1703

2.06

32.08

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4349

40215

1.74

31.69

6.1

5.1

6.2

6.1

mmol/l

4.55

4061

36169

(3049717) Cytology report of Urine Cyto stain

289

1378

2.17

31.69

2.8

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

324

1615

2.08

31.65

2.1

1.4

10.2

10.4

g/l

0.19

263

1328

(3000492) Spirometry study

571

3429

1.75

31.54

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1920

15166

1.44

31.41

5.5

4.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

537

3173

1.78

31.37

2.3

1.8

364.2

369.7

nmol/l

0.26

499

2845

(21494890) Protein electrophoresis panel - 24 hour Urine

124

394

3.20

31.07

1.7

1.2

—

(3020891) Body temperature

345

1779

2.01

30.69

5.6

4.8

—

(3019060) Gas panel - Arterial blood

498

2896

1.80

30.67

5.0

4.7

—

(4010399)

537

3202

1.76

30.36

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

248

1133

2.25

30.21

1.4

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

1630

2.04

30.15

2.2

1.4

3.2

3.1

g/l

1.66

239

1238

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

425

2374

1.87

29.80

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1189

8644

1.50

29.54

4.7

4.0

343.8

489.0

ng/l

0.87

1019

7190

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

524

2.82

29.00

7.1

4.9

506.3

828.3

iu/ml

0.30

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4417

41270

1.73

27.73

6.2

5.5

2.6

mmol/l

8.09

4150

37623

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1368

2.09

27.70

2.1

1.4

36.9

37.6

g/l

1.03

231

1134

(3020961) Endomysium IgA Ab [Titer] in Serum

306

1568

2.02

27.67

1.1

142.0

202.5

titre

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

191

811

2.41

27.55

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

191

811

2.41

27.55

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

229

3.76

27.50

1.8

1.3

22.2

18.8

ug/l

0.30

222

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

265

1291

2.11

27.47

2.2

1.4

0.0

g/l

0.13

235

1164

(3037522) Nuclear Ab [Titer] in Serum

768

5150

1.58

27.42

1.4

1.3

461.4

502.4

titre

0.30

153

1123

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

375

2066

1.88

27.40

3.6

2.5

0.6

0.7

0.35

362

1967

(3034860) Kappa light chains.free [Mass/volume] in Serum

281

1403

2.06

27.29

2.8

1.5

81.1

47.6

mg/l

0.95

249

1128

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

270

1329

2.09

27.24

2.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

280

1399

2.06

27.14

2.8

1.5

42.4

39.5

mg/l

0.23

249

1121

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

274

1359

2.08

27.09

2.8

1.5

6.1

2.3

ratio

0.45

121

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

250

1200

2.14

26.93

2.2

1.4

0.0

g/l

0.00

220

1075

(3025941) Bacteria identified in Stool by Culture

362

1983

1.89

26.91

1.5

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1807

14427

1.40

26.50

3.8

3.2

516.4

282.0

mg/l

1.19

1217

9086

(3029937) Albumin [Presence] in Urine by Test strip

1424

10905

1.43

26.47

5.5

4.2

0.0

estimate

0.96

354

3350

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

245

1175

2.14

26.45

2.2

1.4

0.0

g/l

0.00

219

1070

(3002385) Erythrocyte distribution width [Ratio]

3564

31899

1.43

26.26

29.0

16.4

14.1

13.7

33.75

3508

31076

(3004119) Hemoglobin [Mass/volume] in Venous blood

463

2757

1.75

26.15

4.8

3.1

124.3

130.5

g/l

6.87

455

2678

(40768443) Skin Pathology biopsy report

318

1685

1.95

26.12

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

60.35

25.96

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

270

1354

2.05

25.91

1.7

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

330

1776

1.92

25.88

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4325

40316

1.63

25.78

5.5

4.9

4.4

4.5

mmol/l

7.20

4055

36923

(3020682) Albumin/Creatinine [Ratio] in Urine

1887

15250

1.39

25.43

4.5

4.0

14.8

8.2

mg/mmol

5.44

1283

9548

(3036489) Thrombin time

256

1270

2.07

25.29

2.3

1.8

22.3

21.4

1.02

226

1108

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

375

2118

1.83

25.29

9.1

9.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

390

2234

1.81

25.11

2.7

2.2

11.0

14.5

nmol/l

15.04

334

1930

(3009445) Proteinase 3 Ab [Units/volume] in Serum

341

1874

1.88

25.07

1.5

4.5

17.4

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4174

38652

1.55

24.85

4.9

4.3

1.4

1.3

mmol/l

7.06

3852

34820

(3009508) Creatinine [Moles/volume] in Urine

1824

14716

1.38

24.60

3.7

3.2

7.3

mmol/l

0.08

1542

12227

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4289

39995

1.59

24.39

5.4

4.8

1.4

1.5

mmol/l

2.53

4001

36387

(40760892) CBC W Ordered Manual Differential panel - Blood

1071

7887

1.46

24.21

5.2

4.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

195

893

2.23

23.63

3.3

2.3

3.8

3.5

g/l

1.25

188

839

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

307

3.14

23.22

1.6

1.3

213.3

335.0

u/l

2.36

287

(3013512) EKG study

1637

13072

1.38

23.14

5.0

4.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

170

742

2.34

23.08

1.8

1.5

—

(40768441) Liver Pathology biopsy report

148

4.16

22.84

1.6

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

115

418

2.79

22.82

1.8

1.5

1292.1

2805.8

e6/l

1.51

306

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

188

865

2.22

22.54

2.5

2.2

211.9

194.0

1.85

178

817

(40760888) Immunoglobulin light chains.free panel - Serum

213

1033

2.11

22.35

2.8

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

200

948

2.16

22.26

2.4

2.0

92.4

90.0

0.87

192

883

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

135

542

2.53

22.01

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

257

1348

1.96

21.73

5.0

4.3

3.9

mmol/l

1.10

252

1268

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

207

3.52

21.24

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

229

1163

2.02

21.23

3.7

3.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

300

1670

1.85

21.16

5.5

3.7

24.8

24.9

mmol/l

0.27

280

1521

(3003434) Protein [Mass/volume] in Pleural fluid

121

470

2.61

21.13

1.8

1.5

30.2

29.3

g/l

0.35

108

410

(3023183) Ammonium ion [Moles/volume] in Plasma

176

811

2.21

21.04

3.0

2.6

32.4

34.4

umol/l

0.42

150

695

(3022313) Gas panel - Capillary blood

333

1920

1.79

20.93

5.3

3.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

103

371

2.81

20.82

1.8

1.5

35745.0

63674.3

e6/l

0.51

215

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

125

4.28

20.61

4.0

1.1

47.1

100.1

u/ml

0.65

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

347

2.86

20.45

2.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

281

1552

1.86

20.32

2.3

294.5

704.1

ug/l

2.13

260

1466

(3024891) Influenza virus A+B Ag [Presence] in Specimen

173

807

2.19

20.07

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

915

6748

1.44

20.06

1.3

32.0

39.0

iu/ml

0.81

283

2045

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1936

16127

1.33

19.94

6.2

4.0

2.8

2.4

ug/l

0.56

1769

14453

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

222

3.32

19.76

1.6

1.3

8.0

11.5

u/l

2.85

194

(40768795) Lymph node Pathology biopsy report

4.87

19.63

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

176

835

2.15

19.58

1.4

1.3

—

(3003338) MCHC [Mass/volume]

3567

32520

1.36

19.18

33.1

18.1

330.7

332.2

g/l

17.29

3540

32253

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

409

2558

1.65

19.11

4.9

3.4

1.5

1.9

mmol/l

1.50

318

1864

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

867

6398

1.43

18.81

1.3

1.2

13.0

15.0

u/ml

0.26

288

2318

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

169

802

2.15

18.80

1.7

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1188

9254

1.37

18.78

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

128

541

2.40

18.74

1.5

1.3

—

(3045788) Cell count panel - Pleural fluid

325

2.83

18.72

1.9

1.6

—

(3006462) Nitrate [Presence] in Urine

191

3.44

18.59

4.6

3.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

300

2.90

18.48

1.7

1.4

6.7

mmol/l

0.05

268

(3009343) pH of Capillary blood

418

2655

1.63

18.36

5.0

3.5

7.4

0.06

333

(3008152) Bicarbonate [Moles/volume] in Arterial blood

434

2785

1.61

18.28

8.2

6.9

24.7

24.6

mmol/l

0.14

415

2576

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

260

1450

1.84

18.23

1.5

1.6

63.3

300.6

titre

—

(3019225) pH of Specimen

617

4295

1.50

18.06

5.6

3.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

421

2695

1.62

17.90

5.0

3.5

5.2

kpa

0.25

399

2465

(3012441) Differential panel - Pleural fluid

352

2.70

17.70

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

639

4518

1.48

17.27

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

169

835

2.06

16.94

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

123

3.93

16.77

2.9

2.3

—

(40768806) Pleura Pathology biopsy report

317

2.74

16.72

1.7

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

186

961

1.97

16.47

1.3

1.2

120.0

104.6

titre

0.12

(4211845)

212

3.14

16.40

4.5

3.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

208

1119

1.90

16.35

1.5

1.2

g/l

0.01

199

1049

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

705

2.13

16.35

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

355

2236

1.63

16.10

4.7

3.1

24.9

25.2

mmol/l

1.09

348

2160

(3034770) Mitochondria Ab [Titer] in Serum

187

976

1.95

16.09

1.3

1.2

1742.9

1152.4

titre

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

122

543

2.28

15.93

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

541

3759

1.49

15.88

1.7

1.6

0.82

450

3202

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1140

9025

1.34

15.81

3.4

2.8

0.8

0.7

ug/l

0.44

884

6341

(3027456) Digoxin [Moles/volume] in Serum or Plasma

191

1014

1.92

15.64

3.3

3.2

0.8

nmol/l

0.53

148

801

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

178

923

1.96

15.62

1.1

9.5

6.4

u/ml

0.21

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

577

2.22

15.38

1.8

1.6

0.7

0.9

g/l

1.46

100

435

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

201

1092

1.88

15.34

1.4

1.5

0.2

g/l

0.99

190

1028

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

211

3.06

15.25

1.5

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1567

13027

1.30

15.22

5.3

3.9

21.7

24.1

8.63

850

6543

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

109

472

2.34

15.19

1.7

1.4

119.1

125.4

u/ml

0.17

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

250

1457

1.75

15.15

1.1

2.8

1.3

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

12.54

15.14

1.1

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

106

455

2.36

15.07

1.6

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

106

455

2.36

15.07

1.6

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

110

481

2.32

14.99

1.2

295.9

277.0

u/ml

0.27

301

(3005988) Vibrio sp identified in Specimen by Organism specific culture

106

458

2.34

14.85

1.6

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

269

1610

1.71

14.83

2.1

1.8

1.7

ug/l

0.11

240

1380

(3017181) Myelocytes/100 leukocytes in Blood

464

3169

1.51

14.77

4.4

3.6

0.9

0.7

0.74

142

675

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

210

3.03

14.74

1.6

1.2

—

(3045142) Bone marrow Pathology biopsy report

295

2.67

14.48

1.4

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

115

521

2.24

14.43

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

364

2372

1.58

14.33

1.3

56.7

53.7

au/ml

0.07

103

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

5.31

14.17

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

124

584

2.15

14.15

1.2

1.3

—

(3051651) Icteric interference index of Serum or Plasma

184

3.12

14.10

4.5

4.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

105

463

2.30

14.06

1.6

1.2

—

(3047189) Immunofixation for 24 hour Urine

159

3.29

14.05

1.4

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

477

2.27

13.97

1.6

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

105

467

2.28

13.79

1.6

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

338

2.51

13.78

1.7

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

392

2623

1.54

13.72

2.4

26.5

26.4

au/ml

0.00

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

310

2.57

13.65

1.7

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

194

1084

1.82

13.58

1.6

1.7

—

(3036603) Volume of Urine

233

2.81

13.39

1.4

2235.8

1975.2

0.55

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

392

2.37

13.34

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

198

1121

1.80

13.28

1.5

1.6

12.8

2.8

iu/ml

0.36

255

(3044927) Protein electrophoresis panel - Urine

110

509

2.19

13.15

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

178

988

1.83

12.75

1.9

13.0

11.5

mg/l

1.71

166

900

(3038177) Helicobacter pylori Ab [Presence] in Serum

110

516

2.16

12.72

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

164

889

1.87

12.66

4.5

3.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

117

565

2.10

12.56

1.2

—

(3006270) Folate [Moles/volume] in Blood

378

2.35

12.56

1.3

1.2

329.7

355.4

nmol/l

0.58

302

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

555

2.10

12.37

1.6

1.4

—

(3035880) pH of Pleural fluid

185

2.94

12.11

1.6

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

258

1612

1.63

12.11

1.9

1.8

37.9

38.4

u/l

0.15

217

1360

(3035637) Corticotropin [Mass/volume] in Plasma

330

2.42

12.01

1.3

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

155

3.12

11.92

2.8

1.8

716.0

734.6

e6/l

0.05

(21494434) Karyotype in Bone marrow

314

2.44

11.84

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

327

2177

1.54

11.71

1.4

1.3

207.6

215.9

u/ml

0.09

300

2010

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

245

2.63

11.68

1.9

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

433

3057

1.46

11.64

4.6

3.6

0.1

0.09

122

629

(3026250) Tacrolimus [Mass/volume] in Blood

118

3.41

11.49

37.0

30.8

6.7

7.3

ug/l

1.04

107

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

161

897

1.82

11.43

4.0

2.6

1.9

1.7

mg/l

1.52

153

780

(40757494) Bilirubin.total [Moles/volume] in Blood

245

2.59

11.16

2.5

1.9

20.9

16.7

umol/l

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

491

2.10

11.09

6.8

6.3

12.6

12.1

mg/l

0.46

445

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

147

804

1.85

11.08

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

143

776

1.87

11.05

1.6

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

739

1.88

10.79

1.6

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

311

2.37

10.67

1.2

335.0

141.2

titre

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

155

2.99

10.66

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

102

499

2.07

10.64

1.1

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

400

2.20

10.64

3.8

3.9

—

(4281824)

211

2.67

10.58

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

240

2.56

10.57

1.6

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

235

2.57

10.50

1.6

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

162

2.92

10.47

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

162

2.92

10.47

1.4

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

469

2.09

10.45

1.1

1.5

g/l

0.42

412

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

280

2.41

10.24

1.5

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

280

2.41

10.24

1.5

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

280

2.41

10.24

1.5

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.28

10.10

1.4

1.0

—

(3025159) Blasts/100 leukocytes in Blood

407

2917

1.43

10.09

4.6

3.7

0.0

0.4

0.85

107

552

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

107

544

1.99

10.07

2.9

2.2

26.6

24.8

mg/l

0.11

131

(3042733) HLA Ab [Presence] in Serum

3.61

10.07

5.6

5.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

377

2.20

10.05

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

658

1.89

9.97

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

167

2.83

9.93

1.5

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

167

2.83

9.93

1.5

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

207

2.63

9.88

1.2

35.1

19.2

u/l

0.86

177

(3011412) CD3 cells [#/volume] in Blood

213

2.60

9.86

2.8

2.0

1.0

e9/l

0.05

125

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

299

2027

1.51

9.86

3.3

2.9

4.3

4.4

pmol/l

0.73

249

1740

(3002179) Metamyelocytes/100 leukocytes in Blood

406

2923

1.42

9.82

4.3

3.5

0.5

0.13

107

500

(3009214) Lutropin [Units/volume] in Serum or Plasma

109

563

1.96

9.81

1.5

1.3

12.4

9.8

u/l

0.82

452

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

152

2.91

9.79

2.5

1.8

618.2

427.7

e6/l

0.43

131

(44806118)

388

2.16

9.78

1.6

1.4

—

(44790047)

388

2.16

9.78

1.6

1.4

—

(44790049)

388

2.16

9.78

1.6

1.4

—

(44790048)

388

2.16

9.78

1.6

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

402

2.13

9.72

4.3

3.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

578

4433

1.34

9.51

1.4

—

(1761868) Lipid panel - Serum or Plasma

1043

12427

0.80

9.44

3.4

3.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

213

2.55

9.35

1.2

113.2

81.4

u/l

1.04

183

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

383

2.13

9.29

1.2

54.5

57.6

u/l

0.25

247

(40759836) Histone Ab [Presence] in Serum by Immunoblot

254

2.38

8.96

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

144

2.86

8.88

2.6

1.8

0.3

0.2

e9/l

0.31

130

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

255

2.37

8.88

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

255

2.37

8.88

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

178

2.66

8.85

2.9

2.1

42.0

45.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

7.24

8.84

1.2

1.0

2.7

1.3

ug/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

257

2.35

8.74

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

257

2.35

8.74

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

340

2.16

8.72

3.5

3.0

—

(4062490)

380

2.10

8.69

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

258

2.34

8.66

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

476

1.97

8.64

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

170

1045

1.65

8.60

1.3

1.2

15.1

43.7

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

120

3.01

8.56

3.0

2.3

39.5

42.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

291

2.25

8.56

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

200

2.52

8.45

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

531

4100

1.33

8.32

1.6

—

(40768446) Kidney Pathology biopsy report

133

2.87

8.31

1.6

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

158

963

1.66

8.27

1.3

1.2

1.7

5.5

u/ml

0.67

102

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

144

864

1.69

8.01

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

379

2.05

8.01

1.4

0.6

0.4

g/l

0.40

265

(3027135) IgG subclass 1 [Mass/volume] in Serum

379

2.05

8.01

1.4

6.7

6.9

g/l

0.18

264

(3028192) IgG subclass 2 [Mass/volume] in Serum

379

2.05

8.01

1.4

2.8

2.9

g/l

0.14

264

(3017704) Immunofixation for Urine

230

2.36

8.00

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

158

972

1.65

7.99

1.3

1.2

10.2

5.3

u/ml

0.27

163

(3030981) Hyaline casts [#/volume] in Urine by Automated count

303

2163

1.43

7.71

3.2

2.5

0.2

0.3

e6/l

1.36

295

2114

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

503

1.89

7.71

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

135

806

1.69

7.67

1.2

3.4

4.9

u/ml

—

(3024471) HLA-A [Type]

3.27

7.64

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

217

2.36

7.59

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

211

2.38

7.58

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

3.05

7.57

2.0

2.7

1412.8

583.0

e6/l

0.67

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

264

1847

1.45

7.49

5.3

4.8

1.6

0.01

251

1729

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

231

2.31

7.47

1.6

1.3

37.1

34.9

u/l

0.15

161

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

103

3.02

7.45

6.6

2.0

1.3

1.0

ug/l

0.33

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.86

7.40

2.2

2.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

229

1562

1.49

7.40

2.0

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

195

2.42

7.40

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

482

1.88

7.38

1.6

1.4

—

(3024932) HLA-DR beta [Type]

3.27

7.37

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

260

1823

1.45

7.30

5.4

4.8

0.8

0.9

0.79

247

1707

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

110

2.92

7.26

3.0

2.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

211

2.34

7.12

2.4

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.19

7.10

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

475

1.87

7.06

1.2

3.3

5.2

u/ml

1.25

199

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

139

857

1.64

7.02

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

214

2.30

6.91

1.8

2.0

4.1

1.8

u/field

0.65

144

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

533

4226

1.29

6.88

3.5

3.0

269.6

212.2

ng/l

1.71

486

3894

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

381

1.96

6.85

1.1

2.9

3.4

u/ml

0.18

138

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

524

1.81

6.82

1.5

1.3

—

(40765096) Chromosome analysis panel by Banding

3.78

6.80

1.3

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

196

1319

1.51

6.79

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

240

1682

1.45

6.78

2.1

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

578

1.76

6.72

1.4

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

182

2.37

6.52

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

182

2.37

6.52

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

117

706

1.67

6.45

1.7

1.2

50.1

29.0

u/l

0.58

103

608

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

293

2.06

6.45

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

490

1.81

6.43

1.2

2.1

4.7

u/ml

0.87

152

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

134

838

1.62

6.43

1.3

1.2

—

11.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

289

2.05

6.30

2.1

1.7

324.3

1823.2

u/l

1.03

117

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

183

1237

1.50

6.23

1.5

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

180

2.34

6.21

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

151

2.46

6.09

3.2

2.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

492

1.78

6.07

3.4

2.7

0.9

1.3

0.77

365

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

201

2.25

6.06

1.1

1.0

—

(3048879) Bone marrow aspiration report

2.88

6.03

1.4

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1134

9892

1.19

5.96

1.8

1.7

36177217.1

35989953.2

pmol/l

0.00

973

8019

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.26

5.95

2.0

1.3

—

(3017732) Neutrophils [#/volume] in Blood

347

2646

1.34

5.95

3.1

4.2

4.1

e9/l

0.22

256

1899

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.68

5.91

2.0

1.1

0.3

2.8

mmol/l

0.88

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

119

739

1.63

5.90

1.2

44.3

40.4

u/ml

0.08

(4094501)

176

1195

1.49

5.89

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

154

2.41

5.85

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

178

1215

1.48

5.81

2.2

2.3

203.1

96.8

ug/min

1.56

105

708

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

149

2.43

5.77

2.7

2.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

110

675

1.64

5.73

2.2

1.9

182.1

194.6

pmol/l

0.55

633

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

2.73

5.68

1.5

2.3

2840.0

115734.6

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.85

5.50

1.8

2.5

2461.7

36912.7

e6/l

0.88

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.02

5.36

3.0

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

3.73

5.36

2.3

2.0

154.4

121.1

e6/l

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

161

2.31

5.34

2.7

2.0

15.4

16.2

0.12

(3051593) INR in Capillary blood by Coagulation assay

240

2.05

5.29

8.0

11.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.85

5.25

1.3

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

171

1183

1.46

5.25

1.6

1.5

15062.8

12362.1

e6/l

0.40

126

849

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.21

1.0

0.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

569

1.66

5.20

2.5

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

674

5667

1.22

5.20

4.9

5.0

32.4

33.1

0.73

505

3729

(3025130) Human papilloma virus identified in Specimen

297

1.93

5.19

1.6

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.34

5.16

2.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

139

2.38

5.13

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

280

2118

1.34

5.11

1.2

113.3

133.5

iu/ml

0.37

104

785

(3032057) Clostridioides difficile [Presence] in Stool

2.73

5.09

1.6

1.8

—

(3044007) Cell count panel - Peritoneal fluid

2.85

5.07

2.3

—

(3011985) Renin [Units/volume] in Plasma

552

1.66

5.01

1.2

1.3

86.2

59.7

mu/l

0.59

493

(3033799) Differential panel - Peritoneal fluid

2.70

5.00

1.2

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

953

0.53

4.98

3.8

3.7

31.7

27.3

mg/l

0.35

618

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

211

1533

1.39

4.96

1.7

1.6

—

(3020491) Glucose [Moles/volume] in Blood

291

1.90

4.81

1.6

2.2

7.3

6.8

mmol/l

0.47

191

(3017354) Segmented neutrophils/100 leukocytes in Blood

334

1.84

4.81

3.4

2.5

58.8

59.4

0.08

217

(3023419) Bacteria identified in Sputum by Culture

574

1.63

4.80

2.8

2.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

528

1.66

4.80

1.4

—

(3045414) Leukocytes [Presence] in Urine

252

1896

1.35

4.78

2.1

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

264

1.94

4.76

1.1

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

232

1.99

4.63

1.7

1.5

4.4

8.3

u/l

0.70

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

212

2.04

4.61

1.6

1.3

0.3

nmol/l

0.18

158

(3045424) Erythrocytes [Presence] in Urine

108

699

1.56

4.60

1.5

—

(3042631) Mycobacterium sp identified in Specimen

535

1.64

4.58

2.6

3.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

552

1.62

4.53

1.6

1.3

10.4

4.6

nmol/l

0.25

532

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

508

1.64

4.46

1.5

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

209

2.02

4.41

1.2

273.6

314.0

u/l

0.17

192

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

404

1.72

4.38

1.3

1.7

1.4

nmol/l

1.21

362

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

501

4160

1.23

4.37

4.0

3.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

390

1.73

4.34

1.4

1.7

27.7

23.7

u/ml

0.31

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.66

4.31

1.5

1.3

196.3

96.8

ug/l

0.21

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

135

930

1.46

4.30

2.0

1.8

42.7

43.5

nmol/l

0.18

129

886

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

185

2.06

4.24

1.2

1.1

4.7

13.4

iu/ml

2.87

(3023410) Appearance of Cerebral spinal fluid

341

1.77

4.23

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

146

2.20

4.20

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

558

1.59

4.13

1.6

1.3

0.3

nmol/l

—

(3021788) Differential panel - Synovial fluid

125

857

1.47

4.10

1.4

—

(3028433) Virus identified in Specimen by Culture

122

2.30

4.09

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

631

1.55

4.08

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.71

4.08

1.9

1.1

1.3

1.4

mmol/l

0.13

(4306422)

475

1.63

4.05

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.46

4.04

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.51

4.04

1.3

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

460

1.64

4.03

1.2

119.9

115.3

0.56

408

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

185

1365

1.37

4.03

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

485

1.62

3.98

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

509

1.60

3.96

1.6

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1116

10009

1.15

3.94

4.4

3.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

268

1.84

3.94

1.6

1.8

—

(4268621)

327

1.75

3.92

2.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.64

3.92

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

178

2.03

3.88

1.9

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

162

1180

1.39

3.84

6.2

4.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.84

3.78

16.6

12.0

4.7

5.1

mmol/l

0.36

(3004616) Nuclear Ab [Presence] in Serum

509

1.58

3.74

1.3

—

(3003181) Sodium [Moles/volume] in Urine

112

768

1.47

3.71

1.3

65.6

62.9

mmol/l

0.30

617

(3011544) Albumin [Mass/volume] in Pleural fluid

4.01

3.69

1.0

1.1

12.3

14.8

g/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

633

1.51

3.63

1.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.54

3.62

2.3

2.6

—

102.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.48

3.62

2.6

2.9

6.5

mg/l

0.01

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

514

1.57

3.60

1.2

1.3

266.5

276.0

pmol/l

0.12

388

(3015171) Extractable nuclear Ab [Units/volume] in Serum

199

1517

1.33

3.54

1.2

0.5

0.8

u/ml

0.44

151

(3037692) Legionella sp identified in Specimen by Organism specific culture

124

2.18

3.53

1.6

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

171

2.00

3.53

9.9

5.4

59.6

69.2

mg/l

0.49

116

(3020393) Adenovirus Ag [Presence] in Stool

3.85

3.52

1.1

1.0

—

(3014891) Appearance of Pleural fluid

2.81

3.52

1.3

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

6.16

3.50

1.8

2.4

3.1

mg/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.33

3.49

1.3

1.2

278.5

296.4

pmol/l

0.11

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.33

3.49

1.4

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.55

3.48

1.3

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

341

1.68

3.42

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

364

1.66

3.42

1.6

1.5

—

(44813793)

223

1.85

3.40

1.1

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

141

2.06

3.31

5.7

6.1

66.9

70.9

0.41

118

(4024509)

447

1.57

3.27

1.7

1.6

—

(3022689) Creatine [Moles/volume] in Urine

149

2.02

3.24

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.34

3.24

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

355

1.64

3.22

1.9

2.2

1.9

u/field

0.00

132

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.16

3.21

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

104

726

1.44

3.19

1.2

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

3.19

1.1

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

458

1.56

3.18

1.2

47.1

46.3

u/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

296

1.70

3.15

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.73

3.15

1.1

1.3

11.4

161231.1

nmol/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.96

3.13

2.5

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

103

723

1.43

3.08

3.4

3.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

486

1.53

3.07

1.6

1.3

—

nmol/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

231

1.78

3.07

1.4

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

1.85

3.05

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

1.87

3.05

1.1

—

(1002224) Polysomnography panel

161

1220

1.33

3.04

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

2.18

3.02

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

106

2.18

3.02

1.6

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

2.18

3.02

1.5

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

117

844

1.40

3.01

1.9

1.8

5.8

4.6

iu/l

0.32

271

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

10.01

2.98

4.6

4.2

84.6

15.2

e6/l

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

249

1.73

2.95

2.1

108.8

230.4

ug/min

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

220

1.78

2.92

2.7

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.32

2.90

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

1.90

2.84

1.5

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

151

1148

1.33

2.81

1.8

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.31

2.74

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

356

1.58

2.72

1.3

1.2

95.9

95.7

0.01

331

(3015183) Erythrocyte sedimentation rate

119

2.02

2.65

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.13

2.64

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.80

2.64

2.3

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.80

2.64

2.3

2.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

281

1.64

2.63

1.0

290.3

285.9

mg/l

0.18

253

(3010144) Erythrocytes [#/volume] in Synovial fluid

464

1.49

2.62

1.3

286277.8

189741.8

e6/l

0.34

319

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.66

2.62

4.9

4.0

—

(3029075) Extractable nuclear Ab panel - Serum

2.16

2.60

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

214

1.73

2.58

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

377

1.54

2.58

1.2

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

260

1.66

2.56

2.2

1.4

1.0

0.9

g/l

0.95

260

(3003888) Timothy IgE Ab [Units/volume] in Serum

356

1.55

2.50

1.1

3.7

3.9

u/ml

0.03

169

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

544

1.44

2.48

1.6

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

165

1.82

2.48

1.2

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

653

1.40

2.48

4.5

3.5

60.7

58.5

0.95

653

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

145

1.87

2.41

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

145

1.87

2.41

1.4

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

145

1.87

2.41

1.4

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

145

1.87

2.41

1.4

1.2

—

(40757373) Influenza virus identified in Isolate

2.17

2.40

1.4

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.50

2.35

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

128

979

1.32

2.34

2.2

124.2

130.5

g/l

1.45

734

(3035320) C reactive protein [Mass/volume] in Body fluid

260

1.62

2.32

2.6

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

323

1.55

2.32

1.0

1.1

—

(3025315) Body weight

2.86

2.30

6.9

4.8

—

(3039000) Anion gap in Blood

121

921

1.32

2.30

7.1

6.8

11.1

11.3

mmol/l

0.29

111

819

(3018572) Chloride [Moles/volume] in Blood

121

921

1.32

2.30

7.1

6.8

105.1

104.8

mmol/l

0.35

111

819

(3008401) Mugwort IgE Ab [Units/volume] in Serum

349

1.52

2.26

1.1

0.9

0.7

u/ml

0.18

140

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

3.89

2.25

2.7

2.2

194.3

76.6

pmol/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

11.0

6.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.05

2.21

1.6

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

157

1.79

2.21

2.4

2.0

41.7

53.1

ug/l

1.44

152

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.50

2.18

1.2

59.3

132.4

ug/l

—

(3010421) pH of Blood

135

1053

1.29

2.16

5.1

3.9

7.4

0.10

108

875

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

427

1.46

2.15

1.1

3.1

1.1

u/ml

0.43

168

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.69

2.15

2.9

3.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

181

1.72

2.14

1.2

1.5

11.8

8.8

umol/l

0.29

119

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.30

2.14

1.1

1.2

85.4

78.1

—

(4146454)

562

1.39

2.12

2.8

2.7

—

(3011648) Oxygen content in Venous blood

331

1.52

2.10

2.0

11.1

11.0

0.07

331

(3010726) Horse dander IgE Ab [Units/volume] in Serum

307

1.54

2.10

1.1

1.0

2.9

2.2

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

162

1298

1.26

2.10

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

116

1.90

2.10

1.0

4.1

1.4

u/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

183

1.70

2.07

1.1

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.00

2.07

1.4

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.91

2.07

1.0

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

124

1.86

2.06

1.5

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

374

1.48

2.05

1.0

1.1

—

26.0

—

(40762365) Oxygen content in Arterial blood by calculation

2.32

2.04

3.0

2.2

14.9

15.6

ml/dl

0.34

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.18

2.04

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.40

2.02

2.2

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.11

2.02

1.0

1.1

—

(1616796) Gas panel - Central venous blood

115

889

1.30

2.00

4.5

3.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.82

2.00

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.34

1.96

4.6

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

297

1.52

1.94

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.55

1.94

1.2

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

108

832

1.30

1.93

2.0

1.6

0.9

0.8

nmol/l

1.14

684

(3023511) Choriogonadotropin [Units/volume] in Urine

142

1.76

1.92

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

756

1.32

1.89

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

456

1.41

1.89

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

123

970

1.27

1.86

1.3

1.2

783.6

525.4

mg/l

0.59

115

907

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1235

11582

1.09

1.83

1.7

1.6

1.4

1.3

mmol/l

2.59

1076

9532

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

196

2345

0.83

1.83

1.9

1.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.17

1.82

1.0

—

(3000330) Specific gravity of Urine by Test strip

271

2323

1.18

1.82

5.4

3.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.05

1.80

5.4

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

633

1.33

1.78

1.6

1.3

—

(3004775) Volume in Urine collected for unspecified duration

378

1.43

1.77

2.2

2.4

647.2

632.6

0.09

251

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

218

1840

1.19

1.76

1.3

—

(21494755) Public health laboratory ask at order entry panel

166

2006

0.82

1.74

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

662

1.32

1.73

1.3

35.7

33.5

iu/l

0.20

575

(4015189)

140

1.72

1.71

1.8

2.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.91

1.69

1.1

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.91

1.69

3.5

2.2

—

(3044941) Cell count panel - Synovial fluid

744

1.30

1.69

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

195

1.59

1.68

1.5

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

195

1.59

1.68

1.5

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

408

1.40

1.67

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

164

1.65

1.67

1.5

1.9

3.2

5.5

nmol/l

0.57

133

(3036670) Protein [Mass/volume] in Synovial fluid

164

1.65

1.67

1.2

1.1

39.2

38.7

g/l

0.05

(40765089) Chromosome analysis panel - Blood by G-banded

2.80

1.65

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.33

1.60

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

231

1.52

1.56

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

215

1.54

1.56

1.6

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

207

1.55

1.56

1.1

1.0

0.1

0.3

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.11

1.55

1.2

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

108

862

1.26

1.53

2.6

2.5

15.2

16.3

1.75

463

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.28

1.53

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

332

1.42

1.51

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

106

847

1.26

1.50

1.2

3.6

3.9

mmol/l

1.72

786

(3034426) Prothrombin time (PT)

116

1.73

1.48

1.3

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.44

1.47

1.1

1.2

10.9

10.6

mg/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

125

1524

0.82

1.47

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

334

1.41

1.47

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.22

1.46

1.6

56.8

43.4

umol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

211

1.52

1.45

1.4

1.8

—

7.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

187

1.55

1.45

1.2

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

1.77

1.44

1.2

1.3

—

1230630.0

iu/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

269

1.45

1.43

1.6

1.3

1.1

u/ml

0.00

135

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.92

1.43

3.5

2.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.73

1.43

2.8

2.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

132

1090

1.22

1.40

3.5

3.1

24.5

24.9

mmol/l

0.57

121

960

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.42

1.39

1.0

—

(4034850)

123

1491

0.82

1.39

13.3

10.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

247

1.46

1.37

1.1

1.8

3.0

u/ml

0.41

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.61

1.36

1.5

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

373

3350

1.12

1.35

4.2

3.0

1.2

mmol/l

0.72

337

2818

(3012501) Base excess in Blood by calculation

110

896

1.23

1.34

5.5

4.0

2.9

2.6

mmol/l

0.49

602

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

175

1.55

1.34

1.1

u/l

0.05

(3047181) Lactate [Moles/volume] in Blood

154

1299

1.19

1.32

6.9

6.0

1.2

1.3

mmol/l

0.72

141

1147

(3008898) HLA-B27 [Presence]

119

980

1.22

1.31

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.36

1.29

1.0

1.1

—

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

185

1.52

1.28

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.89

1.28

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

439

1.33

1.27

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.05

1.26

2.1

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

178

1.52

1.25

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

107

1.68

1.25

1.0

7.2

0.6

u/ml

—

(4212803)

2.22

1.24

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.04

1.22

2.7

1.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.63

1.21

1.0

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.63

1.21

1.6

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.63

1.21

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

156

1.54

1.19

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.83

1.19

1.4

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

231

1.43

1.17

1.6

1.5

6.4

6.3

u/l

0.02

194

(3014133) Dog dander IgE Ab [Units/volume] in Serum

265

1.40

1.16

1.1

1.6

2.1

u/ml

0.20

110

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

158

1.52

1.14

1.1

1029.0

500.9

ng/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.96

1.11

2.2

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

1.67

1.10

1.6

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

105

1.62

1.05

11.2

7.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

121

1.57

1.05

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.96

1.03

1.3

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

123

1.55

0.99

10.5

7.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

566

1.24

0.98

1.1

1.2

220.4

201.3

miu/ml

0.12

226

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.18

0.98

1.0

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.18

0.98

2.0

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

198

1.42

0.97

1.1

1.2

134.0

136.9

nmol/l

0.09

198

(3028679) Herpes simplex virus Ab [Presence] in Serum

140

1.50

0.97

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.63

0.97

1.1

81.0

85.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.63

0.97

1.1

85.0

87.1

—

(3017569) Oxygen content in Arterial blood

242

1.37

0.94

2.8

1.8

—

(3021901) Oxygen saturation in Capillary blood

770

1.20

0.93

3.2

2.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

106

899

1.18

0.93

3.2

2.8

7.9

kpa

0.00

101

826

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

118

1.53

0.90

1.4

1.5

0.4

ug/l

0.21

(3043410) Blood group antigens tested for on Red Blood Cells

102

1.57

0.90

1.6

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.87

1.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

343

1.29

0.85

1.8

1.7

—

2026.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

641

1.20

0.85

1.9

1.8

1.9

1.7

mmol/l

1.53

627

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

282

1.31

0.84

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.76

0.83

2.5

2.8

0.4

0.5

u/field

—

(3024263) Appearance of Synovial fluid

248

1.33

0.83

1.9

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

840

1.17

0.79

1.3

16.8

29.1

e6/l

0.51

658

(3008402) Methanol [Moles/volume] in Serum or Plasma

1.82

0.79

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.67

0.78

1.4

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.78

1.0

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

841

1.17

0.78

1.4

519.8

979.8

e6/l

0.77

695

(3014271) Vancomycin [Susceptibility]

251

1.32

0.78

3.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.62

0.78

1.8

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.77

0.76

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.77

0.76

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.70

0.75

1.1

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.75

1.0

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

185

0.65

0.75

1.3

1.2

—

49.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.08

0.74

1.2

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

940

1.15

0.73

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

125

1.44

0.72

2.1

1.5

8.6

9.2

ug/l

0.40

125

(3051101) Glucose [Moles/volume] in Cord blood

108

0.56

0.72

3.7

6.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

203

1.33

0.70

1.1

24.4

24.6

u/l

0.01

143

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

203

1.33

0.70

1.1

84.5

85.8

u/l

0.04

148

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

113

992

1.14

0.69

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

195

1.34

0.69

1.3

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.85

0.68

1.6

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.85

0.68

1.6

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.85

0.68

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.85

0.68

1.6

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.67

0.68

1.4

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.63

0.66

1.7

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.51

0.66

8.5

7.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.72

0.64

1.0

—

(3004451) EKG impression Narrative

225

1.29

0.63

1.2

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.59

0.61

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.61

2.0

1.9

1.5

1.4

mg/l

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.60

0.0

1.5

—

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

157

1.34

0.59

3.0

2.7

26.7

29.0

umol/l

0.54

119

(4027681)

175

1.32

0.58

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

276

0.76

0.58

2.4

1.7

—

69.8

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.72

0.57

1.3

1.0

87.4

48.7

u/ml

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.48

0.57

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.67

0.56

1.7

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.43

0.56

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.56

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.62

0.55

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

458

1.18

0.55

4.4

3.1

45.1

33.4

mg/l

0.30

339

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

366

1.20

0.55

1.3

1.5

—

(3019977) pH of Arterial blood

240

1.25

0.53

3.0

2.2

7.4

0.16

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

610

1.15

0.52

1.4

1.5

65.0

61.3

0.38

388

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

214

1.26

0.52

3.0

4.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.61

0.52

1.5

—

(3022621) pH of Urine by Test strip

301

2830

1.07

0.51

3.8

3.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

102

1137

0.89

0.51

1.6

1.7

3.3

3.5

mg/l

0.11

804

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

135

1.33

0.51

1.1

1254.1

1716.2

miu/ml

1.43

135

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.41

0.50

1.4

93.5

117.9

ng/l

0.56

(4133840)

1.43

0.49

1.3

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.56

0.49

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

236

1.23

0.46

2.4

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

441

1.16

0.44

1.2

8.1

7.8

mmol/l

0.26

309

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.56

0.42

1.4

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.41

0.0

1.2

—

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.43

0.39

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.39

0.0

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

302

0.83

0.38

3.2

13.6

13.3

0.47

297

(3027008) Opiates [Presence] in Urine

459

1.13

0.36

1.2

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

281

1.18

0.36

1.1

1.2

11.2

12.0

mmol/l

0.30

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.35

1.1

—

(3027944) Amphetamines [Presence] in Urine

451

1.13

0.35

1.2

1.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

125

0.72

0.35

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

125

0.72

0.35

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

125

0.72

0.35

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

125

0.72

0.35

1.1

—

(44806071)

1.36

0.34

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

274

1.17

0.33

1.2

—

(3011288) Drugs identified in Urine by Screen method

293

1.16

0.33

1.2

2.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.30

0.33

1.7

1.9

13.0

18.4

umol/l

—

(3028300) Cannabinoids [Presence] in Urine

463

1.12

0.33

1.2

1.7

—

(3008295) Osmolality of Serum or Plasma

397

1.13

0.33

1.3

280.6

276.2

mosm/kgh2o

0.59

303

(3045716) Anion gap in Serum or Plasma

229

1.18

0.32

2.1

2.2

8.6

9.5

mmol/l

0.56

172

(3025577) Chromium [Mass/volume] in Blood

359

0.86

0.31

1.7

2.0

1.9

2.3

ug/l

0.73

298

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

1.25

0.30

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.27

0.30

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

297

1.15

0.29

1.2

1.1

29.8

34.3

mmol/l

0.51

247

(3000764) Benzodiazepines [Presence] in Urine

459

1.11

0.28

1.2

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.29

0.28

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

252

1.15

0.27

1.2

1.1

1.3

9.4

nmol/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

160

0.81

0.26

1.1

—

10.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

123

1.22

0.25

2.4

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

123

1.22

0.25

2.4

2.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.72

0.24

1.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

307

3175

0.96

0.24

5.4

4.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.71

0.24

1.5

2.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

115

1.22

0.23

1.1

1.3

151.4

142.6

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

243

0.86

0.23

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

247

1.13

0.22

1.4

1.1

1.2

nmol/l

0.28

190

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

124

0.81

0.21

1.8

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

267

1.12

0.21

1.6

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

163

1.17

0.21

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.5

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

230

0.87

0.21

1.4

1.5

1.3

4.5

—

(3000012) Reticulocyte production index

240

1.13

0.20

1.2

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.22

0.20

1.2

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.22

0.19

1.7

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.24

0.18

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.24

0.18

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

163

0.86

0.17

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

104

992

1.05

0.17

2.6

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

456

1.08

0.16

1.5

1.4

22.2

30.0

1.02

295

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.18

0.16

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.10

0.15

1.1

—

(3020650) Glucose [Presence] in Urine

1.18

0.14

1.1

1.5

—

(3016879) Cocaine [Presence] in Urine

430

1.07

0.14

1.2

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

597

1.06

0.13

1.0

1.1

5.4

648.8

iu/ml

—

127

(3009466) Valproate [Moles/volume] in Serum or Plasma

569

1.06

0.13

4.5

374.0

354.7

umol/l

0.47

480

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

116

0.86

0.12

1.1

—

(44806420)

164

1.10

0.09

2.5

2.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.09

0.09

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.04

0.09

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.11

0.09

1.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

253

1.07

0.08

1.2

1.4

120.5

201.1

pmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

359

0.95

0.08

1.3

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.82

0.07

1.0

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

296

0.95

0.07

1.1

1.3

1.5

1.3

promille

0.38

225

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

522

1.03

0.06

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

162

0.93

0.06

1.3

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

218

1.06

0.05

1.0

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

391

0.97

0.03

1.0

52.3

47.0

ng/l

0.13

244

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

108

0.93

0.03

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

118

0.93

0.02

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

152

1.05

0.02

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

491

1.02

0.02

1.6

20.9

7.7

7.4

mmol/l

0.31

403

(3005033) Fetal Nuchal fold Thickness US

117

0.94

0.01

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

388

0.98

0.01

1.0

674.4

699.7

ng/l

0.14

242

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

104

1.06

0.01

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

0.94

0.01

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

386

0.98

0.00

1.0

261.4

341.1

ng/l

1.64

248

(3039443) Prostate specific Ag panel - Serum or Plasma

716

0.99

0.00

1.8

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

142

0.99

0.00

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

142

0.99

0.00

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

105

1.05

0.00

1.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

141

0.99

0.00

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

141

0.99

0.00

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

149

1.01

0.00

1.7

2.2

33.0

144.1

umol/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1206.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.98

0.00

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.94

0.00

1.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(4198724)

0.95

0.00

1.0

1.4

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

120

1.00

0.00

1.4

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_ASCENDING_COLON_EXALLC – Benign neoplasm: Ascending colon

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Ascending colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints